Phase Ⅰ study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up

被引:0
|
作者
Zhuang Kang [1 ]
Shan Li [2 ]
Xun Kang [1 ]
Jing Deng [3 ]
Huarong Yang [3 ]
Feng Chen [1 ]
Jiandong Jiang [4 ]
Jie Zhang [3 ]
Wenbin Li [1 ]
机构
[1] Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University
[2] Department of Oncology, Beijing Shijitan Hospital, Capital Medical University
[3] Sichuan Jiuzhang Biological Science and Technology Co. Ltd
[4] Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
关键词
D O I
暂无
中图分类号
R739.4 [神经系肿瘤];
学科分类号
100214 ;
摘要
Objective:This study was aimed at analyzing the efficacy and safety of an injectable form of chlorogenic acid(CGA) in patients with recurrent high-grade glioma after standard of care treatments, through a first-in-human, open-label, dose-escalation phase I trial.Methods:A total of 26 eligible patients were enrolled, received intramuscular CGA injections at 5 dose levels, and were followed up for 5 years. CGA was well tolerated, and the maximum tolerated dose was 5.5 mg/kg.Results:The most common treatment-related adverse events occurred at the sites of injection. No grade 3 or 4 adverse events(e.g., drug allergy) were reported for these patients except for induration at the injection sites. A clinical pharmacokinetic study showed that CGA was rapidly eliminated from the plasma, with a t1/2of 0.95–1.27 h on day 1 and 1.19–1.39 h on day 30, and no detectable CGA was observed on days 9, 11, 13, 23, 25, 27, and 29 before CGA administration. After the first treatment cycle, 52.2% of patients(12 of 23) achieved stable disease. Long-term follow-up indicated an estimated median overall survival of 11.3 months for all 23 evaluable patients. Of the 18 patients with grade 3 glioma, the median overall survival was 9.5 months. Two patients remained alive at the cutoff day.Conclusions:This phase I study demonstrated that CGA has a favorable safety profile(with no severe toxicity), and provides preliminary clinical benefits for patients with high grade glioma relapsing after prior standard therapies, thus shedding light on the potential clinical application of CGA for recurrent grade 4 glioma.
引用
收藏
页码:465 / 476
页数:12
相关论文
共 50 条
  • [1] Phase Ⅰ study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up
    Zhuang Kang
    Shan Li
    Xun Kang
    Jing Deng
    Huarong Yang
    Feng Chen
    Jiandong Jiang
    Jie Zhang
    Wenbin Li
    [J]. Cancer Biology & Medicine., 2023, 20 (06) - 476
  • [2] Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up
    Kang, Zhuang
    Li, Shan
    Kang, Xun
    Deng, Jing
    Yang, Huarong
    Chen, Feng
    Jiang, Jiandong
    Zhang, Jie
    Li, Wenbin
    [J]. CANCER BIOLOGY & MEDICINE, 2023, 20 (06) : 465 - 476
  • [3] Stereotactic Radiosurgery for the Treatment of Recurrent High-grade Gliomas: Long-term Follow-up
    Sallabanda, Kita
    Yanez, Loreto
    Sallabanda, Morena
    Santos, Marcos
    Calvo, Felipe A.
    Marsiglia, Hugo
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [4] First in human phase I study of chlorogenic acid injection in recurrent high grade glioma
    Li, Wenbin
    Ji, Ming
    Xue, Nina
    Kang, Zhuang
    Kang, Xun
    Li, Shan
    Chen, Xiaoguang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Long-term follow-up in high-grade meningioma and outcome analysis
    Singh, Rana Pratap
    Kanjilal, Soumen
    Mehrotra, Anant
    Misra, Shagun
    Tataskar, Pooja
    Mishra, Devanshu
    Verma, Pawan Kumar
    Das, Kuntal Kanti
    Jaiswal, Awadhesh Kumar
    Kumar, Raj
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2024, 15 (02) : 270 - 277
  • [6] Long-term follow-up of Barrett's high-grade dysplasia
    Weston, AP
    Sharma, P
    Topalovski, M
    Richards, R
    Cherian, R
    Dixon, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (08): : 1888 - 1893
  • [7] Morphologically high-grade trichoblastic carcinoma: a clinicopathological study with long-term clinical follow-up
    Mehta, Arjun
    Davey, Jonathan
    Wiedemeyer, Katharina
    Brenn, Thomas
    [J]. HISTOPATHOLOGY, 2021, 78 (07) : 970 - 975
  • [8] LONG-TERM FOLLOW-UP OF CHILDREN TREATED FOR LOW GRADE GLIOMA
    Ater, J. L.
    Xu, A.
    Cruz, S. C.
    Mahajan, A.
    Weinberg, J. S.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : II98 - II98
  • [9] Prognostic value of perfusion MR imaging of high-grade astrocytomas: Long-term follow-up study
    Hirai, T.
    Murakami, R.
    Nakamura, H.
    Kitajima, M.
    Fukuoka, H.
    Sasao, A.
    Akter, M.
    Hayashida, Y.
    Toya, R.
    Oya, N.
    Awa, K.
    Lyama, K.
    Kuratsu, J. -i.
    Yamashita, Y.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (08) : 1505 - 1510
  • [10] TARGETED THERAPY WITH AP 12009 FOR RECURRENT OR REFRACTORY HIGH-GRADE GLIOMA: RESULTS OF A PHASE IIB STUDY WITH EXTENDED FOLLOW-UP
    Bogdahn, U.
    Rappaport, Z. H.
    Olyusin, V.
    Parfenov, V.
    Mahapatra, A. K.
    Mouli, C.
    Venkataramana, N. K.
    Jachimezak, P.
    Heinrichs, H.
    Schlingensiepen, K. -H.
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 836 - 836